From insulin to immunotherapies, clinical trials have powered some of the most important medical breakthroughs of our time.

DelveInsight's " Autosomal Dominant Optic Atrophy Market Insight, Epidemiology And Market Forecast - 2034 " report delivers comprehensive insights into the autosomal dominant optic atrophy treatment ...

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

Clinical trials often face low accrual and retention, and involving communities in their planning and conduct is crucial to ...

New stem cell therapy offers hope for type 1 diabetes, freeing patients from insulin. Learn why diverse clinical trial ...

A patient shares how an event about clinical trials at Moores Cancer Center brought a community together to educate and ...

The annual review of clinical trials for Alzheimer’s highlights a growing number of active trials and drugs that could help ...

Collection of ethnicity data in clinical research has been poor historically, but is essential to ensure that interventions are effective and safe across diverse populations. These data are needed to ...

North America clinical trials market is projected to grow by 7.1% annually in the forecast period and reach $39,268.7 million by 2031, driven by the increasing number of clinical trials and increase ...